Johnson & Johnson Partners with Crucell

In an attempt to further their development of flu vaccines and antibodies, Johnson & Johnson has partnered with Crucell. The partnership, which involves Johnson & Johnson subsidiary Ortho-McNeil-Janssen Pharmaceuticals, will also work to fight other types of diseases but will immediately focus on prevention and treatment of the flu.
Paul Stoffels of Johnson & Johnson recently talked about how a universal vaccine for flu strains would be a huge help in the health care industry.
Said Stoffels: “A universal antibody or vaccine that protects against a broad range of strains would be an important advance in helping doctors and nurses manage the …read more